Childrens Dimetapp Cold & Cough — Class II drug recall D-1362-2020
Terminated recall by Glaxosmithkline Consumer Healthcare Holdings, reported 2020-07-08, distributed nationwide. Defective Delivery System: the dosing cups are missing graduations applicable to certain age groups.
| Recall number | D-1362-2020 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Glaxosmithkline Consumer Healthcare Holdings, Warren, NJ, United States |
| Recall initiated | 2020-06-16 |
| Classified | 2020-06-26 |
| Reported by FDA | 2020-07-08 |
| Terminated | 2022-06-03 |
| Distributed | Nationwide (US) |
| Quantity | 78,132 bottles |
| UPC / GTIN / UDI-DI | 60300312234196 |
| NDC | 00031-2234-19 |
| Lot numbers | CL8292 |
| Expiration dates | 2021-09-30 |
Product
Childrens Dimetapp Cold & Cough, For ages 6 yrs. & over, 8 FL OZ. bottle, (237 mL), Distributed by: Pfizer Madison, NJ 07940, Made in Canada, UPC: 60300312234196, NDC: 0031-2234-19.
Reason for recall
Defective Delivery System: the dosing cups are missing graduations applicable to certain age groups.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-1362-2020. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.